Can Early-Onset Nonoliguric Hyperkalemia Be Predicted in Extremely Premature Infants?

ABSTRACT

Hyperkalemia is common soon after birth in extremely premature infants and often occurs in the absence of oliguria or renal failure. Our objective was to examine the early biochemical indicators, clinical risk factors, and incidence of early-onset nonoliguric hyperkalemia in a cohort of extremely premature infants. We studied clinical and biochemical data from 154 consecutive premature infants ≤ 28 weeks of gestation admitted to a tertiary neonatal unit over a 3-year period. Hyperkalemia (> 7 mmol/L) was found in 33 (21%) of patients during the first 4 days of life, with peak potassium levels occurring at 3 days of age. Hyperkalemic patients had similar birthweight, gestation, creatinine and sodium levels as normokalemic infants, but they had higher phosphate and urea levels, with lower calcium levels. The combination of a high phosphate (> 2.0 mmol/L) and a high potassium (> 5.6 mmol/L) within 6 hours of birth predicted later development of hyperkalemia, with a positive likelihood ratio of 8.3 (post-test probability, 70%). Potassium level of < 5.6 mmol/L at birth indicates subsequent hyperkalemia is unlikely (likelihood ratio, 0.25; post-test probability, 4%). Mildly elevated potassium and phosphate levels within 6 hours after birth may be useful in predicting the development of early-onset hyperkalemia.

Nonoliguric hyperkalemia - prematurity - prediction

REFERENCES

• 1 Vemgal P, Ohlsson A. Interventions for non-oliguric hyperkalemia in preterm neonates.  Cochrane Database Syst Rev. 2007;  (1) CD005257
• 2 Yuan H C, Jeng M J, Soong W J, Chen S J, Hwang B T. Hyperkalemia during the early postnatal days in premature infants.  Acta Paediatr Taiwan. 2003;  44(4) 208-214
• 3 Mildenberger E, Versmold H T. Pathogenesis and therapy of non-oliguric hyperkalemia of the premature infant.  Eur J Pediatr. 2002;  161(8) 415-422
• 4 Mildenberger E, Versmold H. [Results of a National Survey in Germany on incidence and therapy of the nonoliguric hyperkalemia of the premature infant].  Z Geburtshilfe Neonatol. 2002;  206(1) 9-14
• 5 Stefano J L, Norman M E, Morales M C, Goplerud J M, Mishra O P, Delivoria-Papadopoulos M. Decreased erythrocyte Na + ,K( + )-ATPase activity associated with cellular potassium loss in extremely low birth weight infants with nonoliguric hyperkalemia.  J Pediatr. 1993;  122(2) 276-284
• 6 Fiona M, O' Hare E JM. Clinical pattern recognition in the diagnosis of severe hyperkalemia in preterm infant.  In: Pediatric Academic Society Meeting. Toronto; 2007
• 7 Singh D, Dutta S, Narang A. Hyperkalemia and ventricular tachycardia in ELBW infant.  Indian Pediatr. 2003;  40(1) 64-66
• 8 Wren C. Hyperkalemia, cardiac arrhythmias, and cerebral lesions in high risk neonates.  Arch Dis Child. 1988;  63(6) 681-682
• 9 Yalcin Y, Carman D, Shao Y, Ismail-Beigi F, Klein I, Ojamaa K. Regulation of Na/K-ATPase gene expression by thyroid hormone and hyperkalemia in the heart.  Thyroid. 1999;  9(1) 53-59
• 10 Stefano J L, Norman M E. Nitrogen balance in extremely low birth weight infants with nonoliguric hyperkalemia.  J Pediatr. 1993;  123(4) 632-635
• 11 Hung K C, Su B H, Lin T W, Peng C T, Tsai C H. Glucose-insulin infusion for the early treatment of non-oliguric hyperkalemia in extremely-low-birth-weight infants.  Acta Paediatr Taiwan. 2001;  42(5) 282-286
• 12 Bennett L N, Myers T F, Lambert G H. Cecal perforation associated with sodium polystyrene sulfonate-sorbitol enemas in a 650 gram infant with hyperkalemia.  Am J Perinatol. 1996;  13(3) 167-170
• 13 Sato K, Kondo T, Iwao H, Honda S, Ueda K. Internal potassium shift in premature infants: cause of nonoliguric hyperkalemia.  J Pediatr. 1995;  126(1) 109-113
• 14 Mildenberger E, Oels K, Bauer K, Paul M, Versmold H T. Digoxin-like immunoreactive substance in nonoliguric hyperkalemia of the premature infant.  Biol Neonate. 2003;  83(3) 182-187